Effect of rituximab treatment on PCP risk.

Authors
Publication date
Publisher
Doi

    Abstract

    <p>M-H pooled risk ratio = 3.65, fixed effect model method. R: rituximab. Rituximab increased the risk for PCP in lymphoma patients significantly.</p

      Similar works

      Full text

      thumbnail-image

      Available Versions

      The Francis Crick Institute

      redirect
      oaioai:figshare.com:article/13944...
      Last time updated on 12/02/2018